These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20595100)

  • 1. Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.
    Gallamini A
    Haematologica; 2010 Jul; 95(7):1046-8. PubMed ID: 20595100
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative PET: good prognosis for Hodgkin's lymphoma.
    Bagcchi S
    Lancet Oncol; 2015 Jun; 16(6):e265. PubMed ID: 25936985
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P; Sica S; Leone G
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative PET: no guarantee of good prognosis in Hodgkin's lymphoma.
    Adams HJ; Kwee TC
    Ann Hematol; 2015 Sep; 94(9):1609-10. PubMed ID: 26071225
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma.
    Rodríguez-Vigil B; Gómez-León N; Pinilla I; Hernández-Maraver D; Coya J; Martín-Curto L
    Curr Probl Diagn Radiol; 2006; 35(4):151-63. PubMed ID: 16814002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's lymphoma--patient's assessment and staging.
    Gospodarowicz MK
    Cancer J; 2009; 15(2):138-42. PubMed ID: 19390309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
    Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
    Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Pet negativity"--the new goal of cytoreductive therapy in Hodgkin's lymphoma?
    Sweetenham JW
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1569-70. PubMed ID: 21840291
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous regression of primary progressive Hodgkin's lymphoma in a pediatric patient: a case report and review of literature.
    Udupa K; Philip A; Rajendranath R; Sagar T; Majhi U
    Hematol Oncol Stem Cell Ther; 2013; 6(3-4):112-6. PubMed ID: 24120373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma.
    Kluge R; Kurch L; Georgi T; Metzger M
    Semin Nucl Med; 2017 May; 47(3):242-257. PubMed ID: 28417854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma.
    Michelis FV; Exarhos DN; Tzannou IA; Karmiris T; Nikiforakis E
    Acta Oncol; 2011 Apr; 50(3):474-6. PubMed ID: 20715895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Predictive value of positron emission tomography with 18F-FDG in the diagnosis and staging of patients with Hodgkin's lymphoma].
    Khodzhibekova MM
    Vopr Onkol; 2013; 59(4):470-4. PubMed ID: 24032221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to "Role of FDG-PET in the definition and management of involved-field radiation therapy for pediatric Hodgkin's lymphoma."Int J Radiat Oncol Biol Phys (2011;80:324-332).
    Wang J; Shi M
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):494; author reply 494. PubMed ID: 22182722
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    la Fougère C; Hundt W; Bröckel N; Pfluger T; Haug A; Scher B; Hacker M; Hahn K; Reiser M; Tiling R
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1417-25. PubMed ID: 16858568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET scanning and prognosis in Hodgkin's lymphoma.
    Brepoels L; Stroobants S
    Curr Opin Oncol; 2008 Sep; 20(5):509-16. PubMed ID: 19106652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography / computerized tomography evaluation of primary Hodgkin's disease of liver.
    Gota VS; Purandare NC; Gujral S; Shah S; Nair R; Rangarajan V
    Indian J Cancer; 2009; 46(3):237-9. PubMed ID: 19574678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?
    Brepoels L; Stroobants S
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):855-69. PubMed ID: 17908624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.